Status:
RECRUITING
Home And Locally Observed - Tracking (HALO-Trak)
Lead Sponsor:
University College, London
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to collect biometric, HRQoL, immune response and genomic data continuously and intermittently during and after chemo or immunotherapy for the generation of a co...
Detailed Description
The Investigators overarching aim is to determine the relationship between measures of physical performance status including heart rate and steps, health related quality of life (HRQoL) and genomic an...
Eligibility Criteria
Inclusion
- ● A diagnosis of a metastatic or haematological cancer undergoing systemic therapy
- Undergoing at least 1 planned cycle of chemotherapy or immunotherapy, according to standard of care practices.
- Ability to understand and the willingness to sign a written informed consent.
- Able to ambulate without assistance or walking aid.
- Have an Android or iOS phone and willing to download the Ethera app
Exclusion
- ● Physical disabilities that preclude daily walking
- Inability to provide informed consent.
- Unable to use and operate the Ethera Health Monitoring Smartphone App. (Apple or Android)
- Medical or psychiatric condition which in the investigator's opinion would affect the successful completion of the study.
Key Trial Info
Start Date :
January 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05971277
Start Date
January 30 2023
End Date
April 1 2026
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCL London
London, United Kingdom, W1W 7TY